Capstone Triton Financial Group’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-542
Closed -$14K 154
2020
Q4
$14K Buy
+542
New +$11.1K 0.01% 310

Other funds holding CLB

Capstone Triton Financial Group's CLB Position: Q1 2021 in Review

Capstone Triton Financial Group sold out of Core Laboratories (CLB) in Q1 2021, closing a stake of 542 shares — an estimated $14K sold.

Capstone Triton Financial Group first reported a position in CLB in Q4 2020 and held it in 1 quarter. The position peaked at $14K in Q4 2020. 183 funds tracked by Wall St. Rank hold CLB as of Q1 2021.

  • Capstone Triton Financial Group reported no remaining Core Laboratories position as of Q1 2021 after selling out during the quarter.
  • Capstone Triton Financial Group sold 542 Core Laboratories shares in Q1 2021, an estimated $14K.
  • Capstone Triton Financial Group first reported a position in Core Laboratories in Q4 2020 and held it in 1 quarter.
  • Capstone Triton Financial Group's Core Laboratories position peaked at $14K in Q4 2020.
  • 183 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2021.

Based on Capstone Triton Financial Group's 13F filing for Q1 2021, filed 17 May 2021.